The founder of Salymbekov University, Askar Salymbekov, and the vice-president of the university, Rysbek Abdyldaev, met with the leadership of the Cureline Group, a biotechnology company located in San Francisco, USA.
At the meeting, a plan was discussed for opening a biotechnological laboratory in Kyrgyzstan. Cureline Group is an international biotechnology company that conducts large and modern research in the field of medicine. The opening of this laboratory in Kyrgyzstan will make it possible to timely and correctly diagnose oncological diseases and pave the way for large-scale international research.
